These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A novel effective and safe consolidation for patients over 60 years with acute myeloid leukemia: intermediate dose cytarabine (2 x 1 g/m2 on days 1, 3, and 5). Sperr WR, Piribauer M, Wimazal F, Fonatsch C, Thalhammer-Scherrer R, Schwarzinger I, Geissler K, Knöbl P, Jäger U, Lechner K, Valent P. Clin Cancer Res; 2004 Jun 15; 10(12 Pt 1):3965-71. PubMed ID: 15217926 [Abstract] [Full Text] [Related]
23. The treatment of acute myeloid leukemia with mitoxantrone, etoposide and low-dose cytarabine in elderly patients - a report of Polish Acute Leukemia Group (PALG) phase II study. Wrzesien-Kus A, Robak T, Jamroziak K, Wierzbowska A, Dmoszynska A, Adamczyk-Cioch M, Kuliczkowski K, Mazur G, Holowiecki J, Konopka L, Maj S, Marianska B, Zawilska K, Polish Acute Leukemia Group (PALG) phase II study. Neoplasma; 2002 Jun 15; 49(6):405-11. PubMed ID: 12584589 [Abstract] [Full Text] [Related]
24. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB. Cancer Chemother Pharmacol; 2002 May 15; 49 Suppl 1():S13-20. PubMed ID: 12042984 [Abstract] [Full Text] [Related]
25. Oral mucositis in acute lymphoblastic leukaemia: analysis of 169 paediatric patients. Figliolia SL, Oliveira DT, Pereira MC, Lauris JR, Maurício AR, Oliveira DT, Mello de Andrea ML. Oral Dis; 2008 Nov 15; 14(8):761-6. PubMed ID: 18761642 [Abstract] [Full Text] [Related]
26. Combined low-dose cytarabine, melphalan and mitoxantrone for older patients with acute myeloid leukemia or high-risk myelodysplastic syndrome. Yamauchi T, Negoro E, Arai H, Ikegaya S, Takagi K, Takemura H, Inai K, Yoshida A, Urasaki Y, Iwasaki H, Ueda T. Anticancer Res; 2007 Nov 15; 27(4C):2635-9. PubMed ID: 17695426 [Abstract] [Full Text] [Related]
27. [Infection control in neutropenia induced by high-dose cytarabine chemotherapy]. Miyazaki M, Senzaki K, Kiyoi H, Kohno S, Noda Y, Nabeshima T. Gan To Kagaku Ryoho; 2004 Nov 15; 31(12):2011-5. PubMed ID: 15570930 [Abstract] [Full Text] [Related]
28. Five-day infusion of fluorouracil and vinorelbine for advanced breast cancer patients treated previously with anthracyclines. Pieńkowski T, Jagiello-Gruszfeld A. Int J Clin Pharmacol Res; 2001 Nov 15; 21(3-4):111-7. PubMed ID: 12067140 [Abstract] [Full Text] [Related]
29. Recurrent Clostridium difficile diarrhea associated with mitoxantrone and etoposide: a case report and review. Jarvis B, Shevchuk YM. Pharmacotherapy; 1997 Nov 15; 17(3):606-11. PubMed ID: 9165566 [Abstract] [Full Text] [Related]
30. Sequential standard dose mitoxantrone and cytosine arabinoside for newly diagnosed adult acute myeloblastic leukemia. Al Bahar S, Pandita R, Bavishi K, Savani B. Neoplasma; 1999 Nov 15; 46(1):61-5. PubMed ID: 10355536 [Abstract] [Full Text] [Related]
31. Neutropenic infections in 100 patients with non-Hodgkin's lymphoma or Hodgkin's disease treated with high-dose BEAM chemotherapy and peripheral blood progenitor cell transplant: out-patient treatment is a viable option. Seropian S, Nadkarni R, Jillella AP, Salloum E, Burtness B, Hu GL, Zelterman D, Cooper DL. Bone Marrow Transplant; 1999 Mar 15; 23(6):599-605. PubMed ID: 10217191 [Abstract] [Full Text] [Related]
32. Mitoxantrone. Med Lett Drugs Ther; 1988 Jul 01; 30(769):67-8. PubMed ID: 3380059 [No Abstract] [Full Text] [Related]
33. Sequential pilot studies of intensive postremission chemotherapy for acute nonlymphocytic leukemia. Petti MC, Avvisati G, Tafuri A, Meloni G, Amadori S, Mandelli F. Ann N Y Acad Sci; 1987 Jul 01; 511():436-41. PubMed ID: 3326472 [No Abstract] [Full Text] [Related]
34. Etoposide: fifteen years experience. Bernasconi C. Bone Marrow Transplant; 1989 Jan 01; 4 Suppl 1():52-5. PubMed ID: 2653518 [No Abstract] [Full Text] [Related]
35. [Treatment of mucositis with vitamin E during administration of neutropenic antineoplastic agents]. Lopez I, Goudou C, Ribrag V, Sauvage C, Hazebroucq G, Dreyfus F. Ann Med Interne (Paris); 1994 Jan 01; 145(6):405-8. PubMed ID: 7864501 [Abstract] [Full Text] [Related]
36. High frequency of streptococcal bacteraemia during childhood AML therapy irrespective of dose of cytarabine. Johannsen KH, Handrup MM, Lausen B, Schrøder H, Hasle H. Pediatr Blood Cancer; 2013 Jul 01; 60(7):1154-60. PubMed ID: 23281248 [Abstract] [Full Text] [Related]
37. Anthracyclines in the treatment of acute nonlymphocytic leukemias. Boiron M, Jacquillat C, Marty M, Weil M, Gisselbrecht C. Cancer Treat Rep; 1981 Jul 01; 65 Suppl 4():73-6. PubMed ID: 6955013 [No Abstract] [Full Text] [Related]
38. [DCTP (I) combination chemotherapy of adult acute non-lymphocytic leukemia]. Kobayashi T, Ogawa M, Inagaki J, Horikoshi N, Ezaki K, Inoue K, Aiba K, Nagata T, Chinen T, Kuraishi Y, Meguro S, Ichiba K, Abe M. Rinsho Ketsueki; 1982 Nov 01; 23(11):1681-8. PubMed ID: 7166808 [No Abstract] [Full Text] [Related]
39. [Severe neutropenia following cytostatic drug therapy--clinical symptoms, follow-up and prognosis in 26 patients of a district hospital]. Radke EU, Papke J. Z Gesamte Inn Med; 1990 Apr 15; 45(8):219-22. PubMed ID: 2378134 [Abstract] [Full Text] [Related]
40. Intensified prophylaxis of febrile neutropenia with ofloxacin plus rifampin during severe short-duration neutropenia in patients with lymphoma. Muñoz L, Martino R, Subirà M, Brunet S, Sureda A, Sierra J. Leuk Lymphoma; 1999 Aug 15; 34(5-6):585-9. PubMed ID: 10492083 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]